| Title |
Efficacy and Safety of Mildronate for Acute Ischemic Stroke: A Randomized, Double-Blind, Active-Controlled Phase II Multicenter Trial
|
|---|---|
| Published in |
Clinical Drug Investigation, August 2013
|
| DOI | 10.1007/s40261-013-0121-x |
| Pubmed ID | |
| Authors |
Yi Zhu, Guangyun Zhang, Jun Zhao, Deshuai Li, Xiaodong Yan, Juanfang Liu, Xuedong Liu, Haibo Zhao, Jielai Xia, Xiao Zhang, Zhengyi Li, Baorong Zhang, Zongcheng Guo, Lianyuan Feng, Zhaodong Zhang, Fang Qu, Gang Zhao |
| Abstract |
Mildronate, an inhibitor of carnitine-dependent metabolism, is considered to be an anti-ischemic drug. This study is designed to evaluate the efficacy and safety of mildronate injection in treating acute ischemic stroke. |
Mendeley readers
The data shown below were compiled from readership statistics for 41 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Russia | 1 | 2% |
| Unknown | 40 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 11 | 27% |
| Student > Ph. D. Student | 5 | 12% |
| Researcher | 4 | 10% |
| Student > Doctoral Student | 3 | 7% |
| Other | 3 | 7% |
| Other | 6 | 15% |
| Unknown | 9 | 22% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 12 | 29% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 10% |
| Neuroscience | 3 | 7% |
| Sports and Recreations | 3 | 7% |
| Nursing and Health Professions | 2 | 5% |
| Other | 6 | 15% |
| Unknown | 11 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 February 2020.
All research outputs
#2,937,229
of 22,787,797 outputs
Outputs from Clinical Drug Investigation
#66
of 962 outputs
Outputs of similar age
#26,287
of 196,139 outputs
Outputs of similar age from Clinical Drug Investigation
#1
of 17 outputs
Altmetric has tracked 22,787,797 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 962 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.7. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 196,139 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 17 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.